Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon

NCT02632032 | Completed

• 1 other identifier: CDiC-01
• Study Type: interventional
• Target: 46
• Locations: 0 countries
• Sites: N/A

Brief Summary

Therapeutic education is central to the management of diabetes, especially in children and adolescents. Camps represent an ideal environment for education. During camps, the campers receive both theoretical and practical information intended to improve their understanding and self-management of diabetes. The metabolic impact of diabetes camp is little known among children and adolescents living with type 1 diabetes in sub-Saharan Africa. The aimed of this study was to assess the changes in glycemic control and insulin doses in a group of children and adolescents living with type 1 diabetes in Cameroon during and after camp.

Conditions

Type 1 Diabetes

Keywords

Type 1 diabetes; children; diabetes camps; glycemic control

Outcome Measures

Primary Outcomes (1)

• Changes in HbA1c

  Comparing the mean HbA1c of campers from baseline to 3 months and 12 months after camp

  Baseline to 3 months and 12 months after camp

Secondary Outcomes (3)

• Changes in insulin doses

  From the first day to the third day of camp, 3 months and 12 months after camp

• Hypoglycemic episode per camper per day

  From the first day to the third day of camp

• Changes in weight

  Baseline to 3 months and 12 months after camp

Study Arms (1)

Insulin therapy and diabetes education

OTHER

Children and adolescents living with type 1 diabetes already on insulin therapy received collective diabetes education during a five days camp.

Drug: Insulin

Interventions

Insulin DRUG

Monitoring insulin therapy of campers based on their usual regimen (one of the following): * premixed insulin in the morning and evening, * premixed insulin in the morning, regular insulin in the afternoon and premixed insulin in the evening, * regular insulin in the morning and afternoon, and premixed insulin in the evening. Education of campers on different aspects of diabetes care: * monitoring of blood glucose * injection of insulin * adaptation of insulin doses according to blood glucose and during exercise * correction of hypoglycemia * dietary advice

Also known as: regular, NPH and premixed insulin

Insulin therapy and diabetes education

Eligibility Criteria

• Age: 6 Years - 23 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Children living with type 1 diabetes and enrolled in the "Changing Diabetes in Children project".
• Regular follow-up at the Yaoundé Central Hospital.
• Aged between 6 and 23 years old.
• Informed consent signed by parents or guardians prior to enrollment in the CDiC project allowing investigators of the project to used data for research.
• Informed consent forms signed by parents or guardians before participation to the 2013 camp in Yaoundé.

You may not qualify if:

• Nonattendance of the routinely follow-up visits at the CDiC clinic Yaoundé both at 3 and 12 months after camp.

Sponsors & Collaborators

• Yaounde Central Hospital: lead

Related Publications (1)

• Dehayem MY, Takogue R, Choukem SP, Donfack OT, Katte JC, Sap S, Sobngwi E, Mbanya JC. Impact of a pioneer diabetes camp experience on glycemic control among children and adolescents living with type 1 diabetes in sub-Saharan Africa. BMC Endocr Disord. 2016 Jan 20;16:5. doi: 10.1186/s12902-016-0086-x.

  PMID: 26791079 DERIVED

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Insulin

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Autoimmune Diseases; Immune System Diseases

Intervention Hierarchy (Ancestors)

Proinsulin; Insulins; Pancreatic Hormones; Peptide Hormones; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Peptides; Amino Acids, Peptides, and Proteins

Study Officials

• Mesmin Y Dehayem, MD

  Yaounde Central Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Consultant internist and endocrinologist, Yaounde Central Hospital

Study Record Dates

• First Submitted: December 4, 2015
• First Posted: December 16, 2015
• Study Start: July 1, 2013
• Primary Completion: August 1, 2013
• Study Completion: August 1, 2014
• Last Updated: December 17, 2015

Record last verified: 2015-12